Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

Comparison of Cystatin C and β-Trace Protein Versus 99mTc-DTPA Plasma Sampling in Determining Glomerular Filtration Rate in Chronic Renal Disease

Funda Aydin, Evrim Surer Budak, Serkan Demirelli, Ali Ozan Oner, Selen Korkmaz, Gultekin Suleymanlar, Halide Akbas, Fatih Davran and Firat Gungor
Journal of Nuclear Medicine Technology September 2015, 43 (3) 206-213; DOI: https://doi.org/10.2967/jnmt.115.154799
Funda Aydin
1Department of Nuclear Medicine, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evrim Surer Budak
1Department of Nuclear Medicine, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serkan Demirelli
1Department of Nuclear Medicine, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Ozan Oner
2Department of Nuclear Medicine, School of Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Selen Korkmaz
3Department of Biostatistics, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gultekin Suleymanlar
4Department of Internal Medicine, Division of Nephrology, School of Medicine, Akdeniz University, Antalya, Turkey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Halide Akbas
5Department of Biochemistry, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatih Davran
5Department of Biochemistry, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Firat Gungor
1Department of Nuclear Medicine, School of Medicine, Akdeniz University, Antalya, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and cystatin C GFR at confidence level of 95%. sisC = cystatin C.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and β-trace protein GFR at confidence level of 95%. TP2 = β-trace protein.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    (A) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and cystatin C GFR with urinary NAG ≤ 6.1 IU/L, at confidence level of 95%. (B) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and cystatin C GFR with urinary NAG > 6.1 IU/L, at confidence level of 95%. sisC = cystatin C.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    (A) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and β-trace protein GFR with urinary NAG ≤ 6.1 IU/L, at confidence level of 95%. (B) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and β-trace protein GFR with urinary NAG > 6.1 IU/L, at confidence level of 95%. TP2 = β-trace protein.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    (A) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and cystatin C GFR with urinary β2-microglobulin ≤ 0.2 mg/L, at confidence level of 95%. (B) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and cystatin C GFR with urinary β2-microglobulin > 0.2 mg/L, at confidence level of 95%. sisC = cystatin C.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    (A) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and β-trace protein GFR with urinary β2 microglobulin ≤ 0.2 mg/L, at confidence level of 95%. (B) Scatterplot drawn using Bland–Altman analysis showing difference between 99mTc-DTPA GFR and BTP GFR with urinary β2 microglobulin > 0.2 mg/L, at confidence level of 95%. TP2 = β-trace protein.

Tables

  • Figures
    • View popup
    TABLE 1

    Patient Data

    ParameternMinimumMaximumMean±SD
    TPSM8497231.9114.28
    Urinary β2 microglobulin840.228.22.585.86
    Urinary cystatin C840.231.450.350.29
    Serum β2-microglobulin840.815.76.603.69
    Serum cystatin C840.214.281.920.81
    Serum creatinine831.0279.723.168.58
    Serum sodium84118145135.764.77
    Serum phosphorus842.1532.393.953.19
    Serum blood urea nitrogen841222536.0425.77
    Urinary creatinine841.5795.395.6593.63
    Urinary sodium84819358.7033.32
    Urinary phosphorus842.3169.6327.6516.66
    Urinary total protein841.4578.451.8093.03
    Urinary NAG (IU/L)840.3049.2512.068.57
    β-trace protein (ng/mL)84494,8802,108.51920.57
    Serum FT4840.51.51.240.21
    Thyroid-stimulating hormone840.233.7601.863.71
    • View popup
    TABLE 2

    Correlation Between TPSM GFR and GFRs Calculated with the Other Methods

    Groupnβ-trace proteinβ2 microglobulinCystatin CCreatinine
    Total89−0.090 (0.417)−0.762 (<0.0001)−0.797 (<0.0001)−0.033 (0.769)
    19−0.200 (0.606)−0.683 (0.042)
    2330.671* (0.000)0.821* (0.000)
    3380.201 (0.227)0.764* (0.000)
    • ↵* Statistically significant.

    • Data are r values followed by P values in parentheses.

    • View popup
    TABLE 3

    Agreement Between TPSM GFR and Cystatin C and β-Trace Protein GFRs

    ComparisonLimits of agreement*SDMean difference
    Cystatin C and TPSM
     Total−26.5, 3.67.7−11.4
     Group 1−24.8, 6.27.99.3
     Group 2−23.8, 2.36.5−10.8
     Group 3−29.2, 3.38.3−12.9
    β-trace protein and TPSM
     Total−21.4, 23.411.41.0
     Group 1−14.9, 3.24.6−5.9
     Group 2−13.0, 4.84.5−4.1
     Group 3−19.5, 30.912.95.7
    • ↵* 95% confidence interval.

    • View popup
    TABLE 4

    Correlation Between TPSM GFR and β-Trace Protein and Cystatin C GFRs for the 2 Levels of NAG

    NAG level
    Method≤6.1 IU/L (n = 19)>6.1 IU/L (n = 63)P
    Cystatin C0.957 (<0.0001)0.887 (<0.0001)0.0001
    β-trace protein0.801 (<0.0001)0.694 (<0.0001)0.0001
    • Data are r values followed by P values in parentheses.

    • View popup
    TABLE 5

    Correlation Between TPSM GFR and β-Trace Protein and Cystatin C GFRs for the 2 Levels of Urinary β2 Microglobulin

    Urinary β2 microglobulin
    Method≤0.2 (mg/L) (n = 19)>0.2 (mg/L) (n = 63)P
    Cystatin C0.892 (<0.0001)0.839 (<0.01)0.0001
    β-trace protein0.626 (<0.0001)0.722 (<0.0001)0.02
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 43 (3)
Journal of Nuclear Medicine Technology
Vol. 43, Issue 3
September 1, 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Cystatin C and β-Trace Protein Versus 99mTc-DTPA Plasma Sampling in Determining Glomerular Filtration Rate in Chronic Renal Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Comparison of Cystatin C and β-Trace Protein Versus 99mTc-DTPA Plasma Sampling in Determining Glomerular Filtration Rate in Chronic Renal Disease
Funda Aydin, Evrim Surer Budak, Serkan Demirelli, Ali Ozan Oner, Selen Korkmaz, Gultekin Suleymanlar, Halide Akbas, Fatih Davran, Firat Gungor
Journal of Nuclear Medicine Technology Sep 2015, 43 (3) 206-213; DOI: 10.2967/jnmt.115.154799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of Cystatin C and β-Trace Protein Versus 99mTc-DTPA Plasma Sampling in Determining Glomerular Filtration Rate in Chronic Renal Disease
Funda Aydin, Evrim Surer Budak, Serkan Demirelli, Ali Ozan Oner, Selen Korkmaz, Gultekin Suleymanlar, Halide Akbas, Fatih Davran, Firat Gungor
Journal of Nuclear Medicine Technology Sep 2015, 43 (3) 206-213; DOI: 10.2967/jnmt.115.154799
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Does Arthrography Improve Accuracy of SPECT/CT for Diagnosis of Aseptic Loosening in Patients with Painful Knee Arthroplasty: A Systematic Review and Metaanalysis
Show more Imaging

Similar Articles

Keywords

  • Glomerular Filtration Rate
  • cystatin C
  • beta trace protein
SNMMI

© 2025 SNMMI

Powered by HighWire